Gland Pharma’s Q1 FY27 net profit grew 47% YoY to ₹317 crore, despite a 14% sequential decline. Revenue rose 20% YoY to ₹1,800 crore, driven by CDMO and B2B businesses, with strong contributions from the US and Europe markets.
Source :- mint – markets Read More
